Patients News | pharmaphorum

News

Eisai plans ‘patient-proposed’ trial of cancer drug Tazverik

Eisai has reached an agreement with Japan’s National Cancer Centre to run a trial of its EZH2 inhibitor Tazverik in young people with cancers who either have no drug treat

News

ABPI names new members of its patient advisory council

The Association of the British Pharmaceutical Industry (ABPI) has added five new patient organisation figures to its patient advisory council, set up to provide patient pe

News

J&J’s bankruptcy bid to resolve talc claims blocked

Johnson & Johnson’s attempt to draw a line under the ongoing litigation it faces over allegations that its talc products cause cancer has been blocked by an appeals co

News

Clinical trial go-between Inato raises $20m

Inato has raised $20 million in early-stage financing to support the continued development of its clinical trial marketplace, which connects sponsors with its network of t

News

Sword says AI could tackle ‘epidemic’ of unneeded surgery

Sword Health has extended its range of digital interventions for health conditions with the launch of an artificial intelligence-powered programme that can help predict wh

News

FDA clears first OTC Narcan spray for opioid overdose

With the US still battling the opioid epidemic, the most widely-used overdose reversal agent – Emergent BioSolutions’ Narcan – can now be bought over the counter at pharma

Eisai plans ‘patient-proposed’ trial of cancer drug Tazverik

ABPI names new members of its patient advisory council

J&J’s bankruptcy bid to resolve talc claims blocked

Clinical trial go-between Inato raises $20m

Sword says AI could tackle ‘epidemic’ of unneeded surgery

FDA clears first OTC Narcan spray for opioid overdose

Bankruptcy threat looms as Quince runs out of options

How to meet your physicians where they are online

News

Editor's Picks